Diabetes Care, Vol 17, Issue 11 1269-1272, Copyright © 1994 by American Diabetes Association

ARTICLES

The ROC curve in the evaluation of fasting capillary blood glucose as a screening test for diabetes and IGT

AL Bortheiry, DA Malerbi and LJ Franco
Department of Internal Medicine, University of Rio Grande, Brazil.

OBJECTIVE--To assess the performance of different cutoff points of fasting capillary glycemia (FCG) in the diagnosis of diabetes and impaired glucose tolerance (IGT) using the receiver operating characteristics (ROC) curve approach. RESEARCH DESIGN AND METHODS--This study included a sample of 4,019 subjects without a previous history of diabetes who were recruited for a confirmatory 2-h post-glucose challenge capillary glycemia from a larger sample of 21,847 individuals screened with FCG. The sensitivity and the specificity of FCG as a screening test were analyzed in the cutoff range 3.9-8.9 mmol/l, and the corresponding ROC curves were plotted to assess the performance of the test. RESULTS--The screening test performance was better for diabetes than for IGT in the full range of cutoff points studied. Sensitivities ranged between 37.9 and 97.1% for diabetes and 1.8 and 94.4% for IGT; the areas under the ROC curves were 0.91 +/- 0.01 and 0.75 +/- 0.01, respectively. The cutoffs showing the best equilibrium between sensitivity and specificity approached 5.6 and 5.0 mmol/l for diabetes and IGT, respectively. Factors such as age, color, and family history of diabetes can affect the screening test performance. CONCLUSIONS--ROC curves can provide useful information toward improving the usefulness of FCG as a screening test for abnormalities of glucose tolerance.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				P. C. F. Wamba, J. Mi, X.-Y. Zhao, M.-X. Zhang, Y. Wen, H. Cheng, D.-Q. Hou, and K. Cianflone Acylation stimulating protein but not complement C3 associates with metabolic syndrome components in Chinese children and adolescents Eur. J. Endocrinol., December 1, 2008; 159(6): 781 - 790. [Abstract] [Full Text] [PDF]

				A. Tirosh, I. Shai, D. Tekes-Manova, E. Israeli, D. Pereg, T. Shochat, I. Kochba, A. Rudich, and the Israeli Diabetes Research Group Normal Fasting Plasma Glucose Levels and Type 2 Diabetes in Young Men N. Engl. J. Med., October 6, 2005; 353(14): 1454 - 1462. [Abstract] [Full Text] [PDF]

				S. L. Johnson, B. P. Tabaei, and W. H. Herman The Efficacy and Cost of Alternative Strategies for Systematic Screening for Type 2 Diabetes in the U.S. Population 45-74 Years of Age Diabetes Care, February 1, 2005; 28(2): 307 - 311. [Abstract] [Full Text] [PDF]

				S. S. Anand, F. Razak, V. Vuksan, H. C. Gerstein, K. Malmberg, Q. Yi, K. K. Teo, and S. Yusuf Diagnostic Strategies to Detect Glucose Intolerance in a Multiethnic Population Diabetes Care, February 1, 2003; 26(2): 290 - 296. [Abstract] [Full Text] [PDF]

				E. Barrett-Connor The oral glucose tolerance test, revisited Eur. Heart J., August 2, 2002; 23(16): 1229 - 1231. [PDF]

				P.J. Park, S.J. Griffin, L. Sargeant, and N. J. Wareham The Performance of a Risk Score in Predicting Undiagnosed Hyperglycemia Diabetes Care, June 1, 2002; 25(6): 984 - 988. [Abstract] [Full Text] [PDF]

				D. Perucchini, U. Fischer, G. A Spinas, R. Huch, A. Huch, and R. Lehmann Using fasting plasma glucose concentrations to screen for gestational diabetes mellitus: prospective population based study BMJ, September 25, 1999; 319(7213): 812 - 815. [Abstract] [Full Text]

				J. Levy, R. Morris, M. Hammersley, and R. Turner Discrimination, adjusted correlation, and equivalence of imprecise tests: application to glucose tolerance Am J Physiol Endocrinol Metab, February 1, 1999; 276(2): E365 - E375. [Abstract] [Full Text] [PDF]